JOURNAL OF DRUG TARGETING

简称 J DRUG TARGET ·ENGLAND ·出版周期 Bimonthly ·年均收录 88 篇

3.9

最新影响因子

4.40%

自引率

约75%

投稿难度

平均2月

审稿周期

期刊简介

JOURNAL OF DRUG TARGETING是一本专注于药物递送与靶向治疗领域的学术期刊，ISSN号为1061-186X，由英国出版商Taylor & Francis出版，出版地为英国，出版周期为月刊。该期刊的最新影响因子需查阅当年JCR报告，目前为非开放获取（非OA）期刊，被SCI收录，中科院分区需根据最新年度分区表确认，通常位于医学或药学领域的二区或三区。该杂志的发文特点集中于药物递送系统、靶向治疗技术、纳米药物载体、生物分布与药代动力学等研究方向，尤其关注创新性递送策略的临床前与临床研究。其质量较高，审稿严格，对研究的原创性和技术深度要求较高，但可能存在出版周期较长或审稿意见偏保守的风险，适合从事药物递送与靶向治疗领域的研究者投稿。

影响因子趋势

近期发表

Engineered Exosomes for Oral Administration: Breaking Gastrointestinal Barriers for Disease Therapy 2026-09-15

Food Allergen Immunotherapy via Electrospray Coated Microneedles - A Potential Transdermal Therapy 2026-09-15

A Repurposed Olmesartan-Loaded Hyaluronic Acid-Functionalized Lecithin–Chitosan Nanoparticle Hydrogel for Enhanced Topical Delivery in Diabetic Wound Healing 2026-09-14

Acute Effects of Ultrasound-Targeted Microbubble Destruction on Tumor Interstitial Fluid Pressure and Intratumoral Distribution of Doxorubicin and Nab-Paclitaxel in an Orthotopic Breast Cancer Model 2026-09-15

ECM-Mimetic Silk Fibroin/GelMA Hydrogel Integrating Manganese Dioxide Nanozymes and Sustained Nitric Oxide Release for Sequential Immunomodulation and Healing of Chronic Infected Wounds 2026-09-14

Ufasomal nanocarriers for enhanced cardiac delivery of nifedipine: a novel strategy to mitigate doxorubicin-induced cardiotoxicity in breast cancer therapy 2026-09-05

PLGA nanoparticles co-loaded with resveratrol and doxycycline for dual-action periodontal therapy: in vitro and in vivo evaluation 2026-09-12

Silk sericin/fibroin composite drug delivery systems for lung cancer: mechanistic Rationale, potential functional complementarity, and future perspectives 2026-09-05

Rosa damascena -derived nanovesicles restore GAS6-driven efferocytic balance in LPS-induced inflammatory model 2026-09-05

Chitosan nanoparticles for the treatment of ischemia-reperfusion injury: mechanisms, preclinical evidence, challenges, and future perspectives 2026-08-22